Ota Ichiro, Asada Yukinori
Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Nara, Japan.
Department of Head and Neck Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan.
Auris Nasus Larynx. 2020 Aug;47(4):687-691. doi: 10.1016/j.anl.2020.05.006. Epub 2020 May 16.
the pandemic of coronavirus disease 2019 (COVID-19), hospitals worldwide are at risk of nosocomial infection. Preoperative identification of COVID-19 in patients who are scheduled to be admitted to the hospital is essential to preventing the collapse of medical facility. In Japan, the preoperative observation and screening tests with the RT-PCR testing for the new coronavirus (SARS-CoV-2) and chest CT scan are recommended for head and neck cancer surgery during the COVID-19 pandemic.
We conducted surveys of the current situation in Japan through the internet.
Chest CT scan was fully performed (90%), but the RT-PCR testing was not adequately performed (51%).
Although the current screening system can be considered effective to a certain extent, we recommend further widespread use of pre-admission RT-PCR testing not only for patients with head and neck cancer surgery but also for all the hospitalized patients, in order to promote safer treatments, during the COVID-19 pandemic.
在2019冠状病毒病(COVID-19)大流行期间,全球医院都面临医院感染的风险。对计划入院的患者进行术前COVID-19识别对于防止医疗设施崩溃至关重要。在日本,建议在COVID-19大流行期间,对接受头颈癌手术的患者进行术前观察以及采用逆转录聚合酶链反应(RT-PCR)检测新型冠状病毒(SARS-CoV-2)和胸部CT扫描进行筛查。
我们通过互联网对日本的现状进行了调查。
胸部CT扫描的完成率很高(90%),但RT-PCR检测的完成情况不佳(51%)。
尽管当前的筛查系统在一定程度上可被视为有效,但为了在COVID-19大流行期间促进更安全的治疗,我们建议不仅对头颈癌手术患者,而且对所有住院患者进一步广泛开展入院前RT-PCR检测。